MINI FUTURE OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Delayed Börse Stuttgart 20:52:13 16/05/2024 BST | ||
| 6.01 EUR | -0.33% |
|
| Current month | -9.62% | ||
| 1 month | -2.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 16/05/24 | 6.01 | -0.33% |
| 15/05/24 | 6.03 | -5.93% |
| 14/05/24 | 6.41 | -2.29% |
| 13/05/24 | 6.56 | +2.66% |
| 10/05/24 | 6.39 | +1.11% |
Delayed Quote Börse Stuttgart
Last update May 16, 2024 at 08:52 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK4LRG |
| ISIN | DE000JK4LRG6 |
| Date issued | 11/03/2024 |
| Strike | 155.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.63 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.65 € |
|---|---|
| Lowest since issue | 5.57 € |
| Spread | 0.08 € |
| Spread % | 1.31% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.11
USD
Average target price
95.9
USD
Spread / Average Target
+6.43%
- Stock Market
- Certificates
- Certificat
